S. Bae

发表

FcγRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients

K. P. Hong, S. Bae, W. Chung, 2001, Lupus.

The association between FcgRIIIB polymorphisms and systemic lupus erythematosus in Korea

J. S. Lee, D. Yoo, H. Lee, 2005, Lupus.

Phase III Randomized Study of SB5, an Adalimumab Biosimilar, Versus Reference Adalimumab in Patients With Moderate‐to‐Severe Rheumatoid Arthritis

M. Weinblatt, J. Vencovský, J. Choe, 2017, Arthritis & rheumatology.

A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis

S. Bae, C. Kang, Kwangwoo Kim, 2013, Lupus.

Lupus flare associated with growth hormone

T. Y. Kim, S. Lee, D. Yoo, 2001, Lupus.

AB0501 Efficacy and safety of certolizumab pegol (CZP) with concomitant methotrexate (MTX) in korean rheumatoid arthritis (RA) patients (PTS) with an inadequate response to MTX

C. Suh, W. Park, C. Cho, 2013 .

A case report: isolated α heavy chain monoclonal gammopathy in a patient with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin change syndrome

J. Jun, D. Yoo, S. Kim, 2005, International journal of clinical practice. Supplement.

Preliminary Trial of the Efficacy of Bucillamine in Korean Patients with Rheumatoid Arthritis

S. Bae, D. Yoo, S. Kim, 1995 .

Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population.

B. Oh, S. Bae, J. Hong, 2008, Osteoarthritis and cartilage.